Dipeptidyl peptidase 4 inhibitors and their potential immune modulatory functions

Dipeptidyl peptidase 4 (DPP4) inhibitors (DPP4is) are oral anti-diabetic drugs (OADs) for the treatment of type 2 diabetes mellitus (T2DM) through inhibiting the degradation of incretin peptides. Numerous investigations have been focused on the effects of DPP4is on glucose homeostasis. However, ther...

Descripción completa

Detalles Bibliográficos
Autores principales: Shao, Shiying, Xu, QinQin, Yu, Xuefeng, Pan, Ruping, Chen, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7102585/
https://www.ncbi.nlm.nih.gov/pubmed/32061923
http://dx.doi.org/10.1016/j.pharmthera.2020.107503

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7102585/
https://www.ncbi.nlm.nih.gov/pubmed/32061923
http://dx.doi.org/10.1016/j.pharmthera.2020.107503

Ejemplares similares